Redesign Health Inc.
About the Company
Redesign Health is a global asset management platform that empowers builders to launch and scale transformative health technology companies. We help talented operators overcome the unique challenges of healthcare innovation with an ecosystem and suite of capabilities supporting ideation and diligence, commercial traction, and execution. Since 2018, we have launched more than 70 companies that have touched the lives of over 15 million patients and generated more than $1 billion in revenue. We believe we can create breakthrough innovations in global health technology through grit, technical excellence, and teamwork. We seek out builders who share our ambitious vision.
We are seeking an investment executive to drive a new facet of our strategy targeting the AI-driven transformation of incumbent healthcare companies. This is a rare opportunity to lead a category-defining private equity platform at the intersection of healthcare, AI, and value creation. Backed by Redesign Health’s capital, ecosystem, and infrastructure, the Managing Director of AI Venture Buyouts will reimagine control investing for the AI era — building a franchise that scales from a single SPV to a next-generation healthcare buyout fund.
Role Summary: Redesign Health is launching an AI Venture Buyout fund, a next-generation private equity platform that acquires control positions in healthcare companies and uses artificial intelligence to transform how they operate and grow.
Redesign is seeking a Managing Director, AI Venture Buyouts to lead the full lifecycle of this strategy: from sourcing and closing control transactions to driving post-close AI transformation and scaling the platform. This person will lead deal origination and execution, raise capital, and build a repeatable model for AI-enabled value creation across healthcare.
What You’ll Do:
Lead Redesign’s AI-driven buyout strategy focused on healthcare control investments.
Build deal flow through a proprietary network of intermediaries, executives, and operators.
Execute transactions end-to-end, overseeing diligence, modeling, and closing mechanics.
Partner with AI and operating teams to deploy post-close transformation playbooks.
Quantify and communicate impact of AI-driven operating leverage across portfolio companies.
Participate in capital raising
Build and lead a high-performing investment team
Ideal Background:
10–15 years in healthcare private equity or growth equity, with experience leading control investments.
Proven ability to originate, diligence, and close transactions in the healthcare sector.
Strong network across healthcare executives, founders, intermediaries, and strategics.
Fluency in LBO modeling, valuation, and transaction structuring.
Demonstrated success driving value creation through operational and digital transformation.
Experience raising capital and managing institutional investor relationships.
Deep interest in how AI, automation, and data reshape cost structures and enterprise value.
Additional Qualifications and Competencies:
Execution Excellence: Process-oriented and rigorous in managing complex transactions.
Influential Communicator: Commands credibility with LPs, boards, and management teams.
AI-Literate Investor: Understands how emerging technologies drive structural advantage.
Team Leader: Builds small, high-output teams that execute with precision and urgency.
Track record driving measurable value creation in healthcare portfolio companies.
Understanding of payer–provider dynamics, reimbursement, and healthcare regulation.
Additional Information: This position will ideally be based in our NYC headquarters and work collaboratively in office three days/week.
#J-18808-Ljbffr
We are seeking an investment executive to drive a new facet of our strategy targeting the AI-driven transformation of incumbent healthcare companies. This is a rare opportunity to lead a category-defining private equity platform at the intersection of healthcare, AI, and value creation. Backed by Redesign Health’s capital, ecosystem, and infrastructure, the Managing Director of AI Venture Buyouts will reimagine control investing for the AI era — building a franchise that scales from a single SPV to a next-generation healthcare buyout fund.
Role Summary: Redesign Health is launching an AI Venture Buyout fund, a next-generation private equity platform that acquires control positions in healthcare companies and uses artificial intelligence to transform how they operate and grow.
Redesign is seeking a Managing Director, AI Venture Buyouts to lead the full lifecycle of this strategy: from sourcing and closing control transactions to driving post-close AI transformation and scaling the platform. This person will lead deal origination and execution, raise capital, and build a repeatable model for AI-enabled value creation across healthcare.
What You’ll Do:
Lead Redesign’s AI-driven buyout strategy focused on healthcare control investments.
Build deal flow through a proprietary network of intermediaries, executives, and operators.
Execute transactions end-to-end, overseeing diligence, modeling, and closing mechanics.
Partner with AI and operating teams to deploy post-close transformation playbooks.
Quantify and communicate impact of AI-driven operating leverage across portfolio companies.
Participate in capital raising
Build and lead a high-performing investment team
Ideal Background:
10–15 years in healthcare private equity or growth equity, with experience leading control investments.
Proven ability to originate, diligence, and close transactions in the healthcare sector.
Strong network across healthcare executives, founders, intermediaries, and strategics.
Fluency in LBO modeling, valuation, and transaction structuring.
Demonstrated success driving value creation through operational and digital transformation.
Experience raising capital and managing institutional investor relationships.
Deep interest in how AI, automation, and data reshape cost structures and enterprise value.
Additional Qualifications and Competencies:
Execution Excellence: Process-oriented and rigorous in managing complex transactions.
Influential Communicator: Commands credibility with LPs, boards, and management teams.
AI-Literate Investor: Understands how emerging technologies drive structural advantage.
Team Leader: Builds small, high-output teams that execute with precision and urgency.
Track record driving measurable value creation in healthcare portfolio companies.
Understanding of payer–provider dynamics, reimbursement, and healthcare regulation.
Additional Information: This position will ideally be based in our NYC headquarters and work collaboratively in office three days/week.
#J-18808-Ljbffr